Mark Reglinski
Impact in
- Microbiology top 5%
- Bacterial Infections and Vaccines
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Streptococcal Infections and Treatments 11
- Neonatal and Maternal Infections 8
-
- Antimicrobial Resistance in Staphylococcus 8
- Co-authors
- Shiranee Sriskandan (10 shared papers)Nicola N. Lynskey (5 shared papers)Robert J. Edwards (2 shared papers)Jeremy Brown (2 shared papers)Fernanda C. Petersen (2 shared papers)Marina Botto (1 shared paper)Matthew K. Siggins (1 shared paper)Damien Calay (1 shared paper)
- Journals
- PLoS Pathogens (3 papers)npj Vaccines (3 papers)Scientific Reports (2 papers)Journal of Infection (2 papers)Virulence (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Mark Reglinski
17 papers receiving 398 citations
Peers
Comparison fields: 5 of 54
- Microbiology 73
- Infectious Diseases 171
- Public Health, Environmental and Occupational Health 194
- Endocrinology 28
- Clinical Biochemistry 33
Countries citing papers authored by Mark Reglinski
This map shows the geographic impact of Mark Reglinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Reglinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Reglinski more than expected).
Fields of papers citing papers by Mark Reglinski
This network shows the impact of papers produced by Mark Reglinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Reglinski. The network helps show where Mark Reglinski may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Reglinski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 67 | |
| 2 | 2017 | 56 | |
| 3 | 2011 | 54 | |
| 4 | 2018 | 42 | |
| 5 | 2013 | 41 | |
| 6 | 2015 | 36 | |
| 7 | 2016 | 32 | |
| 8 | 2015 | 27 | |
| 9 | 2019 | 16 | |
| 10 | Ex-vivo removal of mammalian immunoglobulin G: method and immunological alterations. | 1978 | 10 |
| 11 | 2021 | 8 | |
| 12 | 2023 | 5 | |
| 13 | 2016 | 5 | |
| 14 | 2019 | 4 | |
| 15 | 2025 | 2 | |
| 16 | 2025 | 2 | |
| 17 | 2023 | 1 |
About Mark Reglinski
Mark Reglinski is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases, Epidemiology, Immunology and Molecular Biology, having authored 17 papers that have together received 408 indexed citations. Recurring topics across this work include Streptococcal Infections and Treatments (11 papers), Antimicrobial Resistance in Staphylococcus (8 papers), Neonatal and Maternal Infections (8 papers), Pneumonia and Respiratory Infections (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Vibrio bacteria research studies (2 papers), Escherichia coli research studies (2 papers) and Bacterial Infections and Vaccines (2 papers). The work is most often cited by research in Microbiology (73 citations), Infectious Diseases (171 citations), Public Health, Environmental and Occupational Health (194 citations), Endocrinology (28 citations) and Clinical Biochemistry (33 citations). Mark Reglinski has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Shiranee Sriskandan, Nicola N. Lynskey, Robert J. Edwards, Jeremy Brown, Fernanda C. Petersen, Marina Botto, Matthew K. Siggins, Damien Calay, Justin C. Mason and Yoon Jung Choi. Their work appears in journals such as PLoS Pathogens, npj Vaccines, Scientific Reports, Journal of Infection and Virulence.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.